Of 63 individuals with available genetic data, 10 had pathogenic mutations in TSC1 and 53 had pathogenic mutations in TSC2. Median age of epilepsy onset was 8 years in individuals with pathogenic variants in TSC1 and <1 year in those with pathogenic variants in TSC2. Here, TSC1 is linked to epilepsy.